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Summary Using an avidin-gold conjugate, the binding and internalization of the biotinylated anti-breast
cancer monoclonal antibody MBrl in MCF-7 cells were examined. After labelling MCF-7 cells at 0WC, MBrl
was found to specifically bind to the entire cell surface. MBrl distribution was diffused in cells fixed before
labelling, but appeared in patches of different sizes in cells immediately fixed after labelling. On warming
prelabelled cells at 37°C for 2 min, MBrl was internalized through non-coated small invaginations and
vesicles an also through smooth invaginations with coated regions at the bottom. After warming for 15 and
30min to 37°C, the MBrl internalization sites were observed as large membrane invaginations, large vesicular
structures and lysosomes. The early steps of MBrl internalization which consists of non-coated micro-
invaginations seem to be correlated to the glycolipidic nature of the MBrl recognized molecule. The MBrl
ability to enter MCF-7 cells suggests that this anti-tumour monoclonal antibody may be used as a toxin
carrier agent.
The characterization of the subcellular localization of
molecules recognized by anti-tumour monoclonal antibodies
(MAbs) as well as of the fate of the antigen-antibody
complex is an important step before determining the
suitability of MAbs for diagnostic and therapeutic
approaches. In particular, to exploit MAbs as carriers of
toxins or drugs, the reagents need to be internalized by the
target cells, either naturally or artificially (Baldwin & Pimm,
1983; Uhr, 1984).
To date, the way anti-tumour MAbs enter different cell
types has not been investigated extensively and only a
limited number of morphological studies have demonstrated
the internalization of MAbs by leukaemia and melanoma
cells (Casellas et al., 1982; Carriere et al., 1985). In this
report, we characterized by immunoelectron microscopy
(IEM) the reactivity of the MAb MBrl, raised against
human breast carcinoma, which recognizes normal and
neoplastic cells of the breast (Menard et al., 1983). The cell
surface sites of MBrl binding and the internalization ability
of the surface-bound MBrl were examined using the breast
cancer cell line MCF-7. The visualization was obtained by
indirect immunolabelling technique using biotinylated MAb
and an avidin-colloidal gold conjugate (A-Au).
Materials and methods
Cell line
The human cell line MCF-7 of breast cancer origin, kindly
provided by Dr J. Fogh (Memorial Sloan-Kettering Cancer
Center, NY), Was maintained in RPMI-1640 (M.A.
Bioproducts, Walkersville, MD) supplemented with 10%
heat-inactivated foetal calf serum, penicillin (100 IUml-1)
and streptomycin (1O00Mgml-).
Monoclonal antibodies
The IgM mouse MAb MBrl raised against human
mammary carcinoma, has already been described (Menard et
al., 1983) and its target antigen on the immunizing tumour
defined (Bremer et al., 1984). The IgM antibodies were
purified from the ascitic fluid of hybridoma-bearing mice by
45% ammonium 'sulphate precipitation and gel filtration on
Sepharose 6B (Pharmacia Fine Chemicals AB, Uppsala,
Sweden) as previously described (Canevari et al., 1985).
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The IgG mouse MAb 66IG10 directed against the human
transferrin receptor was kindly provided by Dr I. Hilgers
(The Netherlands Cancer Institute, Antoni van
Leeuwenhoekhuis, The Netherlands). The IgG antibodies
were purified from the ascitic fluid of hybridoma-bearing
mice by affinity chromatography on a column of protein-A-
Sepharose 4B.
Purified MAbs were biotinylated using an Enzotin Kit
(Enzo Biochem., New York, NY) according to the
manufacturer's suggested procedure.
An enzyme-linked immunosorbent assay (ELISA) using
biotinylated horseradish peroxidase-avidine (Vector
Laboratories, Burlingame, CA) was used to monitor the
efficiency of the MAbs' biotinylation. The test was
performed as previously described (Canevari et al., 1983).
Cell incubation and electron microscopy processing
MCF-7 cells were harvested with trypsin (0.25%), separated
in aliquots of 12 x 106 cells/sample and washed twice in
HEPES-buffered RPMI. The samples were resuspended in
1 ml of the same buffered medium containing 30pg of one or
the other biotinylated MAb and incubated for 1 h at 0°C.
After washing with cold wash buffer (20mM Tris-HCI
pH8.3, 150mm NaCl, 0.1% BSA), the cells were suspended
with 1 ml of A-Au (BRL Products, Gaithersburg, MD)
diluted 1/5 in wash buffer containing 1% BSA and incubated
on ice for another hour. After several washings a sample was
fixed directly by replacing the buffer with 2.5%
glutaraldehyde in 100mM Sorensen buffer, while the other
samples were resuspended in pre-warmed wash buffer and
kept at 37°C for various lengths of time (2, 15 and 30min)
before fixation.
The initial distribution of the sites on the cell surface
which react with the MAbs was also verified by fixing the
cells with 2.5% glutaraldehyde in 100mM Sorensen buffer
before incubation with the immunolabelling reagents.
After glutaraldehyde fixation, all samples were fixed with
2% Os04 in 100mM Sorensen buffer for 1 h at 4°C, de-
hydrated in ethanol series and embedded in Epon 812. The
ultrathin sections were obtained with a LKB ultramicrotome
and observed with an EM 300 electron microscope, after
staining with uranyl acetate and lead citrate.
Results
The biotinylation efficiency of MBrl and 66IG10 was
demonstrated by their specific binding to MCF-7 cells
detected by ELISA. The maximum level of binding was quite
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different between the two antibodies, that of MBrl being
higher than that of 661G10. This difference can be attributed
to the different number of the relevant antigens on the cell
surface as also shown by the direct visualization by IEM (see
below).
To further demonstrate the retention of the antigen
binding activity of MBrl after biotinylation, we compared its
ability to prevent the binding of 1251-labelled MBrl to that
of the unreacted antibody. This inhibition was concentration
related, 50% of the bound counts were inhibited by pretreat-
ment with a similar concentration of biotinylated and non-
biotinylated MBrl (2-3 x 10-8M).
To obtain a single cell suspension suitable for IEM
examination a short treatment with trypsin was adopted. In
fact, previously reported data (Canevari et al., 1983)
indicated that the MBrl recognized molecule was insensitive,
due to its glycolipid nature (Bremer et al., 1984), to even
prolonged proteolytic treatment. In addition, as a control of
the possible alteration of the plasma membrane structure, we
analyzed the pathway of internalization of the transferrin
receptor under the same conditions.
Glutaraldehyde-fixed and unfixed MCF-7 cells, incubated
at 0°C with biotinylated MBrl and A-Au, showed an intense
labelling of the plasma membrane. On fixed cells gold
particles were scattered, singly and in groups of two to three
along the cell surface which included microvilli (Figure la).
On the unfixed cells the labelling commonly appeared as
grouped particles on the microvilli and on the membrane
segments connecting them (Figure lb). The same pattern of
labelling was observed when monolayers of cultured cells
were examined (data not shown).
In MCF-7 cells warmed to 37°C for 2min, gold particles
were more extensively grouped in clusters along certain
distinct membrane segments. They were often associated with
non-coated membrane invaginations and vesicles (Figure Ic)
of small size. Gold particles located near the neck of
unlabelled coated pits and along the smooth walls of deeper
invaginations with coated regions at the bottom (Figure Id
and e) were also visible. The latter labelling pattern was less
frequent than the former one but was always present in all
of the examined sections. The labelling of coated pits and
vesicles was occasional.
After 15min of warming at 37°C the pattern of membrane
labelling was essentially unchanged, but the association of
the labelling with non-coated invaginations and vesicles was
more frequent. In addition, larger invaginations corres-
ponding to membrane fragments (Figure If) and large
cytoplasmic vacuoles (Figure Ig) similar to multivesicular
bodies were found to contain gold particles. After 30min the
surface labelling was still abundant, though reduced to a few
large clusters. The same types of labelled cytoplasmic
structures were present, however lysosomes with gold
Figure 1 Binding and internalization of biotinylated MBrl and A-Au complexes in MCF-7 cells. Gold particles were singly
distributed on the stirface when cells were fixed before labelling (a, x 37,000) whereas small clusters were observed on cells labelled
at 0°C and immediately fixed (b, x47,000). On warming prelabelled cells at 37°C for 2min biotinylated MBrl and A-Au
complexes were internalized via non-coated small vesicles (c, x83,000) and smooth invaginations with coated regions at the
bottom (observe the labelling on the non-coated regions) (d, x92,000 and e, x97,000). After 15min of warming at 37°C, gold
particles were present on large membrane invaginations (f, x44,000) and in large vesicles resembling multivesicular bodies
(g, x 74,000). After 30min of warming at 37°C, lysosomes with gold particles grouped in the dense matrix were also evident
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particles grouped in the dense matrix and mixed with vesicle
and membrane fragments (Figure lh) were also evident.
Membrane labelling was absent when MCF-7 cells were
exposed to non-biotinylated MBrI, or biotinylated irrelevant
antibodies and A-Au either at 0° or 37°C. When the cells
were reacted at 0°C with biotinylated 661GlO and A-Au they
displayed some gold particles scattered on the membrane.
After warming at 37°C the transferrin receptor molecules
displayed their proper pathway of internalization. Warming
for two minutes was sufficient to induce the formation of
coated pits, as previously described (Willingham & Pastan,
1985) and the transferrin receptors reached the lysosomes
through vesicles in a few minutes. Therefore, it seemed
unlikely that the trypsin treatment could have caused a
profound peturbation of the cell membrane structure or that
the cell line used had acquired some endocytotic defect while
in culture.
Discussion
The aim of this work was to characterize the subcellular
localization of the binding site of the anti-tumour MAb
MBrl and the process of its internalization.
The study of MBrI reactivity at O`C showed an intense
and specific labelling of the plasma membrane indicating
that the MBrl recognized molecule is extensively expressed
on the cell surface. The gold particle distribution on fixed
cells indicated that the MBrl binding sites were separately
diffused on the niembrane, whereas in the live cells many of
them were clustered together, thus suggesting ligand induced
redistribution at 0°C. When the cells were warmed up to
37"C, the gold particle clusters increased in size and number,
as a result of a higher degree of lateral displacement of the
MBrl-A-Au complexes.
Moreover, the binding of MBrI to its membrane target
was followed by partial internalization. This finding seems to
be in contrast with our previous data, which by immuno-
fluorescence (IF) on live cells only indicate MBrl staining on
the plasma membrane (Tagliabue et al., 1986). However, by
IEM, even after 30min of warming, only a small fraction of
MBrl was found in intracellular compartments, as compared
with abundant labelling on the cell surface. Although not
quantitatively evaluated, the observed decrease of surface
labelling at 37°C was very low and this could explain the
apparent contrast in results obtained by IEM and IF.
The early steps of MBrl internalization seem to occur
through uncoated plasma membrane invaginations, since
only a very small number of coated pits were labelled. This
is consistent with data concerning the pathway of endo-
cytosis of ligands such as cholera and tetanus toxins
(Montesano et al., 1982) which bind with a membrane
glycolipid. By contrast, it is well known that for ligands with
glycoproteins as receptor sites endocytosis proceeds
essentially by coated invaginations (Goldsten et al., 1979).
The glycolipid nature of the MBrl recognized molecule
(Bremer et al., 1984) therefore supports the hypothesis that
the surface events which lead to the internalization of a
ligand depend on the chemical nature of its receptor. In this
respect, the observation that the uncoated invaginations
which internalize MBrl frequently have coated pits at the
bottom, is particularly interesting. This pattern seems to
suggest that the cell entry of MBrl could also be indirect if
mediated by other physiological ligands which enter by
coated pits.
The present results have been obtained by an indirect
labelling technique which requires the intervention of a
second labelled reagent. The latter may have influenced the
pattern of membrane and intracellular labelling, due to its
valency or chemical nature. Therefore, we cannot conclude
that the behaviour of the biotinylated MBrl-A-Au
complexes reflects that of the non-biotinylated MBrl. The
immunolabelling of the internalized unlabelled MBrl with
gold labelled second reagent, performed in cryosections or
permeabilized cells, could overcome the problem, even if this
approach would imply a loss of ultrastructural details.
Nevertheless, if we assume that the unmodified antibody
behaves in the same way, as described in this paper, the
demonstration of partial internalization of MBrl after
binding to a specific membrane molecule could be in favor
of its possible use as a toxin carrier agent. In fact, in spite of
its isotype and its not strictly tumour-specific pattern of
reactivity, one is able to hypothesize some clinical appli-
cations for MBrl such as in vitro selective removal of
metastatic cells from bone marrow in the perspective of bone
marrow transplantation after high-dose chemotherapy and/or
radiotherapy and in vivo regional therapy. We have already
reported the successful generation of an immunoconjugate
derived from the coupling of the ricin A chain with MBrl
(Canevari et al., 1985). Interestingly, the slow kinetics of the
toxic effects of this conjugate can be attributed to the slow
and only partial process of internalization.
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